Literature DB >> 20484812

Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice.

Kazutaka Ueda1, Hiroyuki Takano, Yuriko Niitsuma, Hiroshi Hasegawa, Raita Uchiyama, Toru Oka, Masaru Miyazaki, Haruaki Nakaya, Issei Komuro.   

Abstract

Erythropoietin reportedly has beneficial effects on the heart after myocardial infarction, but the underlying mechanisms of these effects are unknown. We here demonstrate that sonic hedgehog is a critical mediator of erythropoietin-induced cardioprotection in mice. Treatment of mice with erythropoietin inhibited left ventricular remodeling and improved cardiac function after myocardial infarction, independent of erythropoiesis and the mobilization of bone marrow-derived cells. Erythropoietin prevented cardiomyocyte apoptosis and increased the number of capillaries and mature vessels in infarcted hearts by upregulating the expression of angiogenic cytokines such as VEGF and angiopoietin-1 in cardiomyocytes. Erythropoietin also increased the expression of sonic hedgehog in cardiomyocytes, and inhibition of sonic hedgehog signaling suppressed the erythropoietin-induced increase in angiogenic cytokine expression. Furthermore, the beneficial effects of erythropoietin on infarcted hearts were abolished by cardiomyocyte-specific deletion of sonic hedgehog. These results suggest that erythropoietin protects the heart after myocardial infarction by inducing angiogenesis through sonic hedgehog signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484812      PMCID: PMC2877931          DOI: 10.1172/JCI39896

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.

Authors:  D S Sohal; M Nghiem; M A Crackower; S A Witt; T R Kimball; K M Tymitz; J M Penninger; J D Molkentin
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes.

Authors:  M Funamoto; Y Fujio; K Kunisada; S Negoro; E Tone; T Osugi; H Hirota; M Izumi; K Yoshizaki; K Walsh; T Kishimoto; K Yamauchi-Takihara
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

Authors:  D S Silverberg; D Wexler; D Sheps; M Blum; G Keren; R Baruch; D Schwartz; T Yachnin; S Steinbruch; I Shapira; S Laniado; A Iaina
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

4.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

Authors:  M Digicaylioglu; S A Lipton
Journal:  Nature       Date:  2001-08-09       Impact factor: 49.962

5.  The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors.

Authors:  R Pola; L E Ling; M Silver; M J Corbley; M Kearney; R Blake Pepinsky; R Shapiro; F R Taylor; D P Baker; T Asahara; J M Isner
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

6.  Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1.

Authors:  P M Lewis; M P Dunn; J A McMahon; M Logan; J F Martin; B St-Jacques; A P McMahon
Journal:  Cell       Date:  2001-06-01       Impact factor: 41.582

7.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

8.  Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.

Authors:  Norio Suzuki; Osamu Ohneda; Satoru Takahashi; Masato Higuchi; Harumi Y Mukai; Tatsutoshi Nakahata; Shigehiko Imagawa; Masayuki Yamamoto
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

9.  Medulloblastoma growth inhibition by hedgehog pathway blockade.

Authors:  David M Berman; Sunil S Karhadkar; Andrew R Hallahan; Joel I Pritchard; Charles G Eberhart; D Neil Watkins; James K Chen; Michael K Cooper; Jussi Taipale; James M Olson; Philip A Beachy
Journal:  Science       Date:  2002-08-30       Impact factor: 47.728

10.  Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.

Authors:  Chanil Moon; Melissa Krawczyk; Dongchoon Ahn; Ismayil Ahmet; Doojin Paik; Edward G Lakatta; Mark I Talan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

View more
  33 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models.

Authors:  Johannes Vogel; Max Gassmann
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

Review 3.  Targeting the hedgehog signaling pathway for cardiac repair and regeneration.

Authors:  Y Wang; P Lu; D Zhao; J Sheng
Journal:  Herz       Date:  2016-11-22       Impact factor: 1.443

Review 4.  The role of Hedgehog signaling in fibrogenic liver repair.

Authors:  Steve S Choi; Alessia Omenetti; Wing-Kin Syn; Anna Mae Diehl
Journal:  Int J Biochem Cell Biol       Date:  2010-11-05       Impact factor: 5.085

5.  Regulatory Effects of Neuroinflammatory Responses Through Brain-Derived Neurotrophic Factor Signaling in Microglial Cells.

Authors:  Sheng-Wei Lai; Jia-Hong Chen; Hsiao-Yun Lin; Yu-Shu Liu; Cheng-Fang Tsai; Pei-Chun Chang; Dah-Yuu Lu; Chingju Lin
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

6.  Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.

Authors:  Rajesh Katare; Federica Riu; Kathryn Mitchell; Miriam Gubernator; Paola Campagnolo; Yuxin Cui; Orazio Fortunato; Elisa Avolio; Daniela Cesselli; Antonio Paolo Beltrami; Gianni Angelini; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

7.  Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion.

Authors:  Akshay Pratap; Ravikiran Panakanti; Ningning Yang; James D Eason; Ram I Mahato
Journal:  Pharm Res       Date:  2010-08-25       Impact factor: 4.200

8.  In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.

Authors:  Andrei Todica; Mathias J Zacherl; Hao Wang; Guido Böning; Nathalie L Jansen; Carmen Wängler; Peter Bartenstein; Michael C Kreissl; Marcus Hacker; Stefan Brunner; Sebastian Lehner
Journal:  J Nucl Cardiol       Date:  2014-09-05       Impact factor: 5.952

Review 9.  Cell-based therapy for prevention and reversal of myocardial remodeling.

Authors:  Vasileios Karantalis; Wayne Balkan; Ivonne H Schulman; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

10.  Gi proteins mediate activation of the canonical hedgehog pathway in the myocardium.

Authors:  Christian J Carbe; Lan Cheng; Sankar Addya; Jessica I Gold; Erhe Gao; Walter J Koch; Natalia A Riobo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-09       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.